{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=QOL+Questionnaire&page=3", "query": { "intervention": "QOL Questionnaire", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 1300, "total_pages": 130, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=QOL+Questionnaire&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=QOL+Questionnaire&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-27T09:26:29.749Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03284346", "title": "Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer Survivor", "No Evidence of Disease", "Obesity", "Overweight", "Prostate Carcinoma", "Sedentary Lifestyle", "Stage I Breast Cancer", "Stage IA Breast Cancer", "Stage IB Breast Cancer", "Stage II Breast Cancer", "Stage IIA Breast Cancer", "Stage IIB Breast Cancer", "Stage III Breast Cancer", "Stage IIIA Breast Cancer", "Stage IIIB Breast Cancer", "Stage IIIC Breast Cancer" ], "interventions": [ { "name": "Exercise Intervention", "type": "BEHAVIORAL" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Polar heart rate monitor", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 23, "start_date": "2017-08-17", "completion_date": "2019-07-15", "has_results": false, "last_update_posted_date": "2025-09-29", "last_synced_at": "2026-10-27T09:26:29.749Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03284346" }, { "nct_id": "NCT04719273", "title": "Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Refractory Endometrial Adenocarcinoma", "Refractory Endometrial Carcinoma", "Refractory Endometrial Clear Cell Adenocarcinoma", "Refractory Endometrial Endometrioid Adenocarcinoma", "Refractory Endometrial Mixed Cell Adenocarcinoma", "Refractory Endometrial Serous Adenocarcinoma", "Refractory Endometrial Undifferentiated Carcinoma" ], "interventions": [ { "name": "Extended-release Onapristone", "type": "DRUG" }, { "name": "Anastrozole", "type": "DRUG" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Estrogen Receptor Positive (Positive Estrogen Receptor; ESR Positive; ESR1 Positive; ER Positive; Estrogen Receptor Alpha Positive)", "type": "DIAGNOSTIC_TEST" }, { "name": "Progesterone Receptor Positive ( PGR Positive; PR Positive)", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "OTHER", "DIAGNOSTIC_TEST" ], "sponsor": "Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 14, "start_date": "2021-01-28", "completion_date": "2025-12-17", "has_results": true, "last_update_posted_date": "2026-07-17", "last_synced_at": "2026-10-27T09:26:29.749Z", "location_count": 2, "location_summary": "Abington, Pennsylvania • Philadelphia, Pennsylvania", "locations": [ { "city": "Abington", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04719273" }, { "nct_id": "NCT01176006", "title": "Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "DOCK8 Deficiency" ], "interventions": [ { "name": "Reduced-intensity hematopoietic stem cell", "type": "PROCEDURE" }, { "name": "Fludarabine(Fludara, Berlex Laboratories)", "type": "DRUG" }, { "name": "Cyclophosphamide(CTX, Cytoxan)", "type": "DRUG" }, { "name": "Total Body Irradiation (TBI)", "type": "PROCEDURE" }, { "name": "Busulfan (Busulfex)", "type": "DRUG" }, { "name": "Donor peripheral blood stem cell mobiliation and collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Harvest Procedure", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "4 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "4 Years to 120 Years" }, "enrollment_count": 76, "start_date": "2010-10-05", "completion_date": "2028-10-31", "has_results": false, "last_update_posted_date": "2026-10-26", "last_synced_at": "2026-10-27T09:26:29.749Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01176006" }, { "nct_id": "NCT07850284", "title": "SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "AL Amyloidosis", "Multiple Myeloma" ], "interventions": [ { "name": "Non-Interventional Study", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2026-08-25", "completion_date": "2028-08-25", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-10-27T09:26:29.749Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07850284" }, { "nct_id": "NCT05704036", "title": "Estrogen Supplementation and Bone Health in Women With CF", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cystic Fibrosis", "Hypoestrogenism" ], "interventions": [ { "name": "Transdermal estrogen", "type": "DRUG" }, { "name": "Progesterone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": "100 Years", "sex": "FEMALE", "summary": "0 Years to 100 Years · Female only" }, "enrollment_count": 75, "start_date": "2023-05-02", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2025-11-14", "last_synced_at": "2026-10-27T09:26:29.749Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05704036" }, { "nct_id": "NCT06524973", "title": "Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Metastatic Pancreatic Adenocarcinoma" ], "interventions": [ { "name": "Telemedicine", "type": "OTHER" }, { "name": "Counseling", "type": "OTHER" }, { "name": "Best Practice", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Inrweview", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 136, "start_date": "2024-10-07", "completion_date": "2027-05-03", "has_results": false, "last_update_posted_date": "2026-09-10", "last_synced_at": "2026-10-27T09:26:29.749Z", "location_count": 22, "location_summary": "Arcadia, California • Corona, California • Duarte, California + 16 more", "locations": [ { "city": "Arcadia", "state": "California" }, { "city": "Corona", "state": "California" }, { "city": "Duarte", "state": "California" }, { "city": "Duarte", "state": "California" }, { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06524973" }, { "nct_id": "NCT00684801", "title": "Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Colorectal Cancer", "Lung Cancer", "Ovarian Cancer", "Pancreatic Cancer" ], "interventions": [ { "name": "questionnaire administration", "type": "OTHER" }, { "name": "quality-of-life assessment", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "Case Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 605, "start_date": "2007-08", "completion_date": "2011-12", "has_results": false, "last_update_posted_date": "2015-10-09", "last_synced_at": "2026-10-27T09:26:29.749Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00684801" }, { "nct_id": "NCT01305200", "title": "Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Childhood Acute Lymphoblastic Leukemia in Remission", "Childhood Acute Myeloid Leukemia in Remission", "Childhood Chronic Myelogenous Leukemia", "Childhood Myelodysplastic Syndromes", "Chronic Eosinophilic Leukemia", "Chronic Myelomonocytic Leukemia", "Chronic Neutrophilic Leukemia", "de Novo Myelodysplastic Syndromes", "Disseminated Neuroblastoma", "Juvenile Myelomonocytic Leukemia", "Mucositis", "Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable", "Previously Treated Childhood Rhabdomyosarcoma", "Previously Treated Myelodysplastic Syndromes", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Recurrent Childhood Large Cell Lymphoma", "Recurrent Childhood Lymphoblastic Lymphoma", "Recurrent Childhood Rhabdomyosarcoma", "Recurrent Childhood Small Noncleaved Cell Lymphoma", "Recurrent Malignant Testicular Germ Cell Tumor", "Recurrent Wilms Tumor and Other Childhood Kidney Tumors", "Recurrent/Refractory Childhood Hodgkin Lymphoma", "Relapsing Chronic Myelogenous Leukemia", "Secondary Acute Myeloid Leukemia", "Secondary Myelodysplastic Syndromes", "Unspecified Childhood Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "supersaturated calcium phosphate rinse", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" }, { "name": "questionnaire administration", "type": "OTHER" }, { "name": "quality-of-life assessment", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "4 Years to 21 Years" }, "enrollment_count": 226, "start_date": "2011-03", "completion_date": "2015-06-30", "has_results": true, "last_update_posted_date": "2019-09-17", "last_synced_at": "2026-10-27T09:26:29.749Z", "location_count": 31, "location_summary": "Arcadia, California • Duarte, California • Oakland, California + 26 more", "locations": [ { "city": "Arcadia", "state": "California" }, { "city": "Duarte", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01305200" }, { "nct_id": "NCT03865992", "title": "Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer", "Joint Pain" ], "interventions": [ { "name": "Curcumin", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Nanoemulsion", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire", "type": "BEHAVIORAL" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER", "BEHAVIORAL" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 42, "start_date": "2019-04-30", "completion_date": "2027-08-04", "has_results": false, "last_update_posted_date": "2026-10-19", "last_synced_at": "2026-10-27T09:26:29.749Z", "location_count": 4, "location_summary": "Duarte, California • Rancho Cucamonga, California • South Pasadena, California + 1 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Rancho Cucamonga", "state": "California" }, { "city": "South Pasadena", "state": "California" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03865992" }, { "nct_id": "NCT03532971", "title": "Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "BK Virus Infection" ], "interventions": [ { "name": "Symptom index questionnaire", "type": "OTHER" }, { "name": "BK polyomavirus PCR", "type": "DIAGNOSTIC_TEST" }, { "name": "quality of life questionnaires", "type": "OTHER" } ], "intervention_types": [ "OTHER", "DIAGNOSTIC_TEST" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2018-07-30", "completion_date": "2020-09-14", "has_results": false, "last_update_posted_date": "2024-05-22", "last_synced_at": "2026-10-27T09:26:29.749Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03532971" } ] }